Genetics
Expert Discusses Genetic Predisposition to Prostate Cancer in Racially Diverse Patient Populations
BY CURTIS A. PETTAWAY, MD
Addressing Treatment For Patients At The Highest Risk of BRCA Mutations
BY SUSAN M. DOMCHEK, MD
Family History Could Provide the Necessary Data to Anticipate Lung Cancer
BY CAROLINE SEYMOUR
Genetic Testing for BRCA Mutations is Vital in Breast Cancer Treatment
BY CONOR KILLMURRAY
Quality of Life Data for PARP Inhibitor Shows Promise for Pancreatic Cancer Treatment
BY EILEEN M. O'REILY, MD
Protect Yourself and Your Patients From Fraud in Genetic Testing
BY LISA SCHLAGER
4 Questions With a Genetic Counselor
BY BRIELLE BENYON
New USPSTF BRCA Recommendations Still Fall Short
BY BRIELLE BENYON
ctDNA Monitoring Is Important for BRAF-Mutant Melanoma
BY DANIELLE TERNYILA
External Resources
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.